Drug Trial Radar · NCT02348606
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
Last checked: Nov 20, 2026Latest source record: Jul 23, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
476
Actual
Start
May 2015
Primary completion
Dec 2016
Study completion Dec 2016
Sponsor
- Lead sponsor
- Jazz PharmaceuticalsJazz Pharmaceuticals (JAZZ)
- Sponsor type
- Industry
- First posted
- Jan 28, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial is a 12 week, randomized, double-blind, placebo controlled, multicenter, 5-arm parallel group study of safety and efficacy of JZP-110 in the treatment of excessive sleepiness in adult subjects with OSA.
Conditions
- Obstructive Sleep Apnea
Interventions
JZP-110Drug
Placebo oral tabletDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Maintenance of Wakefulness Test (MWT) From Baseline to Week 12Time frame: Baseline to Week 12
- Change in ESS Score From Baseline to Week 12Time frame: Baseline to Week 12
Locations
59 sites in 5 countries. Site status is shown where the registry gives one.
Pulmonary Associates
Glendale, Arizona
Mayo Clinic in Arizona
Scottsdale, Arizona
Preferred Research Partners
Little Rock, Arkansas
UC San Diego Medical Center
La Jolla, California
So Cal Institute For Respiratory Diseases, Inc.
Los Angeles, California
Pacific Sleep Medicine
Oceanside, California
Stanford University Center for Narcolepsy
Redwood City, California
Pacific Research Network, Inc.
San Diego, California
PAB Clinical Research
Brandon, Florida
MD Clinical
Hallandale, Florida
Clinical Research Group of St. Petersburg
St. Petersburg, Florida
Florida Pediatric Research Institute
Winter Park, Florida
NeuroTrials Research Inc.
Atlanta, Georgia
SleepMed of Central Georgia
Macon, Georgia
Northwestern University Feinberg School of Medicine
Chicago, Illinois
University of Illinois at Chicago College of Nursing
Chicago, Illinois
Kentucky Research Group
Louisville, Kentucky
Johns Hopkins Hospital
Baltimore, Maryland
The Center for Sleep & Wake Disorders
Chevy Chase, Maryland
Neurocare, Inc.
Newton, Massachusetts
Henry Ford Hospital Sleep Disorders & Research Center
Detroit, Michigan
Clinical Neurophysiology Services
Sterling Heights, Michigan
Minnesota Lung Center
Edina, Minnesota
Sleep Medicine & Research Center, St. Luke's Hospital
Chesterfield, Missouri
University of Missouri
Columbia, Missouri
Clayton Sleep Institute
St Louis, Missouri
Clinilabs
New York, New York
Montefiore Medical Center
The Bronx, New York
Duke University Medical Center
Durham, North Carolina
Hickory Research Center
Hickory, North Carolina
Hickory Research Center, ARSM Research, LLC
Huntersville, North Carolina
Raleigh Neurology Associates
Raleigh, North Carolina
Northcoast Clinical Trials Inc.
Beachwood, Ohio
Sleep Management Institute
Cincinnati, Ohio
CTI Clinical Research Center
Cincinnati, Ohio
Case Western Reserve University
Cleveland, Ohio
Southwest Cleveland Sleep Research Center
Cleveland, Ohio
Cleveland Clinic
Cleveland, Ohio
Ohio Sleep Medicine & Neuroscience Institute
Dublin, Ohio
Mercy St. Anne & Mercy St. Charles Sleep Disorders Center
Toledo, Ohio
Showing 40 of 59 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.